|
HPS5 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.53930251562451E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.54081217071689E-14 |
| Normal-vs-Stage2 |
5.274100E-02 |
| Normal-vs-Stage3 |
1.118130E-03 |
| Normal-vs-Stage4 |
1.6386599999918E-05 |
| Stage1-vs-Stage2 |
2.764000E-03 |
| Stage1-vs-Stage3 |
1.027690E-02 |
| Stage1-vs-Stage4 |
5.528800E-01 |
| Stage2-vs-Stage3 |
5.611600E-01 |
| Stage2-vs-Stage4 |
2.058400E-01 |
| Stage3-vs-Stage4 |
3.369400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.36808358980534E-12 |
| Normal-vs-AfricanAmerican |
1.90529999555267E-08 |
| Normal-vs-Asian |
1.815410E-01 |
| Caucasian-vs-AfricanAmerican |
5.427000E-01 |
| Caucasian-vs-Asian |
2.884600E-01 |
| AfricanAmerican-vs-Asian |
4.421400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.92423854628032E-12 |
| Normal-vs-Female |
1.247310E-04 |
| Male-vs-Female |
8.077400E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.35300001494699E-09 |
| Normal-vs-Extreme_Weight |
1.6278089987054E-12 |
| Normal-vs-Obese |
3.27180000003757E-06 |
| Normal-vs-Extreme_Obese |
1.62929999492079E-08 |
| Normal_Weight-vs-Extreme_Weight |
2.311800E-01 |
| Normal_Weight-vs-Obese |
3.267400E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.264000E-01 |
| Extreme_Weight-vs-Obese |
2.615600E-02 |
| Extreme_Weight-vs-Extreme_Obese |
4.506200E-01 |
| Obese-vs-Extreme_Obese |
3.746200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.179400E-01 |
| Normal-vs-Age(41-60Yrs) |
3.95320443047353E-11 |
| Normal-vs-Age(61-80Yrs) |
2.06723527185204E-13 |
| Normal-vs-Age(81-100Yrs) |
8.95659999500253E-08 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.073800E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.044300E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.472100E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.481560E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.003800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.066600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62492241884138E-12 |
| Normal-VS-Type2 PRCC |
5.73030000117214E-08 |
| Normal-VS-KIRP CIMP |
1.664800E-01 |
| Normal-VS-Unclassified PRCC |
4.295700E-03 |
| Type1 PRCC-VS-Type2 PRCC |
8.960200E-03 |
| Type1 PRCC-VS-KIRP CIMP |
3.424300E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
1.360910E-03 |
| Type2 PRCC-VS-KIRP CIMP |
1.080290E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
1.653030E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.004500E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.58570001573821E-09 |
| Normal-vs-N1 |
2.633800E-01 |
| Normal-vs-N2 |
8.40040000000819E-05 |
| N0-vs-N1 |
1.474350E-02 |
| N0-vs-N2 |
5.979000E-01 |
| N1-vs-N2 |
1.458390E-01 |
|
|
